« Back
Home /
Oridonin

Oridonin

Manufacturer	MedChem Express
Category	Neuroscience Metabolism Diabetes Aging & Neurological Disorders Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	200 mg
Item no.	HY-N0004-200mg
Targets	Akt; Bacterial
CASRN	28957-04-2
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Oridonin (NSC-250682), a diterpenoid isolated from Rabdosia rubescens, acts as an inhibitor of AKT, with IC50s of 8.4 and 8.9 μM for AKT1 and AKT2; Oridonin possesses anti-tumor, anti-bacterial and anti-inflammatory effects.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	364.43
Clinical_Information	Phase 4
Manufacturers Research_Area	Cancer; Infection; Inflammation/Immunology
Solubility	DMSO : 62.5 mg/mL (ultrasonic)
Manufacturers Target	Akt; Bacterial
Isoform	Akt1; Akt2
Pathway	Anti-infection; PI3K/Akt/mTOR
Manufacturers Product type	Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-N0004-200mg-safety-datasheet.pdf